Print this page    •   Back to Web version of article

HIV 101: Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis in Patients Taking PIs or NNRTIs

February 2004

HIV 101: Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis in Patients Taking PIs or NNRTIs

Updated January 20, 2004. Adapted from the Centers for Disease Control and Prevention: www.cdc.gov/nchstp/tb/tb_hiv_drugs/Table1.htm and www.cdc.gov/nchstp/tb/tb_hiv_drugs/Table2.htm.




This article was provided by Brown Medical School. It is a part of the publication HEPP Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art13018.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.